Hansa Biopharma AB (publ) (HNSBF) Short Interest Ratio & Short Volume $3.00 0.00 (0.00%) As of 01/8/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Hansa Biopharma AB (publ) Short Interest DataHansa Biopharma AB (publ) (HNSBF) has a short interest of 541,000 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1,352.5, indicating that it would take 1,352.5 days of the average trading volume of 1,800 shares to cover all short positions.Current Short Interest541,000 sharesPrevious Short Interest541,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.53 millionShort Interest Ratio1,352.5 Days to CoverLast Record DateDecember 15, 2024Today's Trading Volume0 sharesAverage Trading Volume1,800 sharesToday's Volume Vs. Average0% Short Selling Hansa Biopharma AB (publ)? Sign up to receive the latest short interest report for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHNSBF Short Interest Over TimeHNSBF Days to Cover Over TimeHNSBF Percentage of Float Shorted Over Time Hansa Biopharma AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2024541,000 shares $1.53 million No ChangeN/A1352.5 $2.83 11/30/2024541,000 shares $1.97 million No ChangeN/A0 $3.65 11/15/2024541,000 shares $1.97 million No ChangeN/A0 $3.65 10/31/2024541,000 shares $1.97 million -0.3%N/A5410 $3.65 10/15/2024542,400 shares $1.59 million No ChangeN/A0 $2.93 9/30/2024542,400 shares $1.59 million +0.3%N/A0 $2.93 Get the Latest News and Ratings for HNSBF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024541,000 shares $1.59 million -1.0%N/A0 $2.93 8/31/2024546,600 shares $1.60 million +1.7%N/A0 $2.93 8/15/2024537,500 shares $1.57 million +10.9%N/A0 $2.93 7/31/2024484,500 shares $1.42 million -0.9%N/A1615 $2.93 7/15/2024489,000 shares $1.43 million -2.2%N/A0 $2.93 6/30/2024499,900 shares $1.46 million -6.5%N/A0 $2.93 6/15/2024534,700 shares $1.57 million -2.7%N/A0 $2.93 5/31/2024549,700 shares $1.61 million -4.8%N/A0 $2.93 5/15/2024577,600 shares $1.69 million No ChangeN/A0 $2.93 4/30/2024577,600 shares $1.69 million -2.1%N/A0 $2.93 4/15/2024590,200 shares $1.73 million +0.7%N/A0 $2.93 3/31/2024586,300 shares $1.72 million -1.8%N/A0 $2.93 3/15/2024596,900 shares $1.94 million +4.4%N/A746.1 $3.26 2/29/2024571,500 shares $1.86 million -0.2%N/A0 $3.26 2/15/2024572,600 shares $1.86 million +7.7%N/A2863 $3.26 1/15/2024451,800 shares $1.20 million -0.6%N/A4518 $2.65 12/31/2023454,600 shares $1.03 million -0.4%N/A235.2 $2.26 12/15/2023456,200 shares $1.37 million -0.2%N/A0 $3.00 11/30/2023457,000 shares $1.37 million +3.0%N/A0 $3.00 11/15/2023443,500 shares $1.33 million -2.4%N/A0 $3.00 10/31/2023454,500 shares $1.36 million -15.7%N/A0 $3.00 10/15/2023538,800 shares $1.62 million -0.2%N/A5388 $3.00 9/30/2023539,800 shares $2.12 million -0.5%N/A0 $3.93 9/15/2023542,500 shares $2.13 million No ChangeN/A5425 $3.93 8/31/2023542,500 shares $2.13 million +0.4%N/A1629 $3.93 8/15/2023540,200 shares $2.57 million +0.4%N/A0 $4.76 7/31/2023538,300 shares $2.85 million +1.6%N/A2691.5 $5.30 7/15/2023530,100 shares $2.81 million +3.2%N/A0 $5.30 6/30/2023513,600 shares $2.72 million -0.1%N/A0 $5.30 6/15/2023514,200 shares $2.72 million -0.1%N/A0 $5.30 5/31/2023514,700 shares $2.73 million -0.4%N/A0 $5.30 5/15/2023517,000 shares $2.74 million -0.4%N/A574.4 $5.30 4/30/2023519,100 shares $2.70 million +0.2%N/A0 $5.20 4/15/2023517,900 shares $2.69 million -0.3%N/A0 $5.20 3/31/2023519,200 shares $2.70 million +3.3%N/A0 $5.20 3/15/2023502,600 shares $2.61 million -11.4%N/A5026 $5.20 2/28/2023567,000 shares $2.95 million +2.8%N/A0 $5.20 2/15/2023551,600 shares $2.87 million +16.0%N/A2758 $5.20 1/31/2023475,700 shares $3.14 million -0.9%N/A528.6 $6.60 1/15/2023480,000 shares $2.40 million +9.5%N/A1600 $5.01 12/30/2022438,400 shares $2.16 million -8.8%N/A0 $4.93 12/15/2022480,700 shares $2.37 million +2.0%N/A4807 $4.93 11/30/2022471,200 shares $2.27 million +2.7%N/A0 $4.82 11/15/2022458,700 shares $2.21 million +6.5%N/A655.3 $4.82 10/31/2022430,800 shares $2.48 million +0.5%N/A0 $5.75 10/15/2022428,500 shares $2.46 million -10.8%N/A0 $5.75 9/30/2022480,200 shares $2.76 million +7.9%N/A0 $5.75 9/15/2022445,000 shares $2.56 million +20.5%N/A4450 $5.75 8/31/2022369,400 shares $2.09 million +12.0%N/A284.2 $5.66 8/15/2022329,800 shares $1.87 million -22.2%N/A0 $5.66 7/31/2022424,000 shares $2.40 million +26.9%N/A0 $5.66 7/15/2022334,100 shares $1.89 million -18.6%N/A0 $5.66 6/30/2022410,600 shares $2.32 million -12.3%N/A0 $5.66 6/15/2022467,900 shares $2.65 million -10.6%N/A0 $5.66 5/31/2022523,400 shares $2.96 million -5.4%N/A0 $5.66 5/15/2022553,200 shares $3.13 million -0.7%N/A1383 $5.66 4/30/2022557,000 shares $3.25 million -0.2%N/A5570 $5.84 4/15/2022557,900 shares $3.96 million +0.6%N/A5579 $7.10 3/31/2022554,600 shares $5.13 million +7.9%N/A0 $9.25 3/15/2022513,900 shares $4.75 million -9.6%N/A0 $9.25 2/28/2022568,200 shares $5.26 million +7.4%N/A0 $9.25 2/15/2022528,900 shares $4.89 million +26.7%N/A5289 $9.25 1/31/2022417,400 shares $3.86 million +43.8%N/A0 $9.25 1/15/2022290,300 shares $2.69 million +180.5%N/A725.8 $9.25 12/31/2021103,500 shares $1.05 million -1.1%N/A0 $10.10 12/15/2021104,600 shares $1.06 million -10.0%N/A209.2 $10.10 11/30/2021116,200 shares $2.11 million +10.9%N/A0 $18.20 11/15/2021104,800 shares $1.91 million +0.3%N/A0 $18.20 10/29/2021104,500 shares $1.90 million -5.4%N/A0 $18.20 10/15/2021110,500 shares $2.01 million +0.1%N/A0 $18.20 9/30/2021110,400 shares $2.01 million +1.9%N/A0 $18.20 9/15/2021108,400 shares $1.97 million -27.4%N/A0 $18.20 8/31/2021149,200 shares $2.72 million -2.6%N/A0 $18.20 8/13/2021153,100 shares $2.79 million -23.6%N/A0 $18.20 7/30/2021200,400 shares $3.65 million -16.7%N/A0 $18.20 7/15/2021240,500 shares $4.38 million -9.0%N/A0 $18.20 6/30/2021264,200 shares $4.81 million +33.1%N/A1321 $18.20 6/15/2021198,500 shares $3.25 million -38.7%N/A0 $16.40 5/28/2021323,800 shares $5.31 million +3.4%N/A129.5 $16.40 5/14/2021313,200 shares $5.32 million -8.2%N/A0 $16.99 4/30/2021341,300 shares $5.80 million -13.2%N/A0 $16.99 4/15/2021393,200 shares $6.68 million +18.0%N/A0 $16.99 3/31/2021333,300 shares $5.66 million +15.9%N/A833.3 $16.99 3/15/2021287,500 shares $8.48 million -12.3%N/A0 $29.50 2/26/2021327,800 shares $9.67 million No ChangeN/A0 $29.50 2/12/2021327,800 shares $9.67 million -2.8%N/A0 $29.50 1/29/2021337,200 shares $9.95 million -25.2%N/A3372 $29.50 1/15/2021341,300 shares $10.07 million +107.4%N/A0 $29.50 12/31/2020342,900 shares $10.12 million +0.5%N/A0 $29.50 12/15/2020341,300 shares $10.07 million +107.4%N/A0 $29.50 11/30/2020164,600 shares $4.86 million +207.7%N/A0 $29.50 11/15/202053,500 shares $1.58 million +25.9%N/A535 $29.50 10/30/202042,500 shares $1.19 million -12.9%N/A0 $28.03 10/15/202048,800 shares $1.37 million +0.4%N/A25.7 $28.03 9/30/202048,600 shares $1.32 million -0.2%N/A486 $27.14 9/15/202048,700 shares $1.32 million +0.2%N/A0 $27.14 8/31/202048,600 shares $1.32 million +0.2%N/A0 $27.14 8/14/202048,500 shares $1.39 million -24.8%N/A0 $28.65 7/31/202064,500 shares $1.85 million -53.5%N/A13.7 $28.65 7/15/2020138,700 shares $3.70 million -25.3%N/A693.5 $26.70 6/30/2020185,600 shares $4.96 million -21.3%N/A1856 $26.70 6/15/2020235,700 shares $4.24 million -17.8%N/A0 $17.97 5/29/2020286,600 shares $3.81 million -22.9%N/A0 $13.30 5/15/2020371,900 shares $4.95 million -16.8%N/A0 $13.30 4/30/2020446,800 shares $3.73 million +3.4%N/A893.6 $8.34 4/15/2020432,300 shares $0.00 -6.9%N/A0 $0.00 3/31/2020464,400 shares $3.87 million +26.5%N/A0 $8.34 3/13/2020367,200 shares $3.06 million +140.5%N/A0 $8.34 2/28/2020152,700 shares $0.00 +60.4%N/A117.5 $0.00 2/14/202095,200 shares $793,968.00 -2.4%N/A952 $8.34 1/31/202097,500 shares $813,150.00 -3.1%N/A88.6 $8.34 1/15/2020100,600 shares $788,704.00 +3.3%N/A1006 $7.84 HNSBF Short Interest - Frequently Asked Questions What is Hansa Biopharma AB (publ)'s current short interest? Short interest is the volume of Hansa Biopharma AB (publ) shares that have been sold short but have not yet been covered or closed out. As of December 15th, traders have sold 541,000 shares of HNSBF short. Learn More on Hansa Biopharma AB (publ)'s current short interest. What is a good short interest ratio for Hansa Biopharma AB (publ)? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HNSBF shares currently have a short interest ratio of 1,352.0. Learn More on Hansa Biopharma AB (publ)'s short interest ratio. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Hansa Biopharma AB (publ) stock? Short selling HNSBF is an investing strategy that aims to generate trading profit from Hansa Biopharma AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hansa Biopharma AB (publ)? A short squeeze for Hansa Biopharma AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HNSBF, which in turn drives the price of the stock up even further. How often is Hansa Biopharma AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HNSBF, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies 180 Life Sciences Short Interest Data 3SBio Short Interest Data Agentix Short Interest Data Algernon Pharmaceuticals Short Interest Data Alpha Tau Medical Short Interest Data Anew Medical Short Interest Data Apollomics Short Interest Data Ascentage Pharma Group International Short Interest Data Avacta Group Short Interest Data Awakn Life Sciences Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HNSBF) was last updated on 1/10/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation These ten investments legendary financial analyst Porter Stansberry is exposing after he spent time at Mar-a-L...Porter & Company | SponsoredGreatest crypto bull market in history?Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, Bitcoin has outperformed stocks,...Stansberry Research | SponsoredBOMBSHELL revelation: TRUMP 2028!!!Legendary venture capitalist and former hedge fund manager James Altucher predicted Trump would win. And no...Paradigm Press | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hansa Biopharma AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Hansa Biopharma AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
